NCT06103812 is a clinical trial of Hyalo4 Skin Gel in Wound Heal, sponsored by Fidia Farmaceutici s.p.a..

Who is sponsoring NCT06103812?

NCT06103812 is sponsored by Fidia Farmaceutici s.p.a..

What drugs are being tested in NCT06103812?

Interventions in NCT06103812: Hyalo4 Skin Gel.

What condition does NCT06103812 study?

NCT06103812 studies Wound Heal.

Is NCT06103812 still recruiting?

NCT06103812 is currently status unknown. Last updated 27 October 2023.

Last reviewed 2023-10-27 · How we verify

NCT06103812

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluate Performance and Safety of Hyalo4 Skin in Acute and Chronic Wounds

Status unknown Last updated 27 October 2023

What this trial tests

trial testing Hyalo4 Skin Gel in Wound Heal in 170 participants. Status unknown.

Timeline

24 March 2022

Primary endpoint
28 August 2023

31 January 2024

Quick facts

Lead sponsor	Fidia Farmaceutici s.p.a.
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	170
Start date	24 March 2022
Primary completion	28 August 2023
Estimated completion	31 January 2024
Sites	6 locations across Slovakia

Drugs / interventions tested

Hyalo4 Skin Gel

Conditions studied

Wound Heal — all drugs for Wound Heal →

Sponsor

Fidia Farmaceutici s.p.a. — full company profile →

Who can join

18 and older, any sex, with Wound Heal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the performance and safety of the use of Hyalo4 Skin Gel in terms of wound management

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Wound Heal

Currently open trials in the same condition.

NCT07261501 — An Exploratory Research on the Efficacy and Safety of Antibacterial Absorbable Dressing in Chronic Non-healing Wounds · NA · recruiting
NCT07209358 — EDX110 Randomized Control Trial for Treatment of DFUs · NA · recruiting
NCT06522438 — Hyaluronic Acid and Octenidine Gel as an Adjunct to Non-surgical Periodontal Treatment · NA · recruiting
NCT06841237 — Randomized Controlled Trial on the Efficacy and Safety of Xiang Lei Ointment in Diabetic-related Ulcer Management · NA · recruiting
NCT06563323 — Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) · Phase 2 · recruiting

Other Fidia Farmaceutici s.p.a. trials

Trials by the same sponsor.

NCT06190028 — Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Gl · NA · terminated
NCT06108999 — Management of Acute and Chronic Wounds With Hyaluronic Acid · NA · recruiting
NCT06062771 — Efficacy and Safety of the Use of Ophthalmic Viscosurgical Devices (OVD) FIDIAL PLUS vs IAL®-F During Cataract Surgery · NA · completed
NCT04757038 — An Open Label, Randomized-controlled Trial to Assess Efficacy Safety of HYALODISC With Physical Exercise Program · NA · unknown
NCT06528600 — Comparative Study of Two Hyaluronic Acid Formulation in the Management of Knee Osteoarthritis · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06103812 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fidia Farmaceutici s.p.a.
Last refreshed: 27 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06103812.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing